⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for pancreatic acinar cell carcinoma

Every month we try and update this database with for pancreatic acinar cell carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Carboplatin and Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Metastatic Pancreatic CancerNCT01280058
Pancreatic Acin...
Pancreatic Duct...
Recurrent Pancr...
Stage IV Pancre...
Carboplatin
Laboratory Biom...
Paclitaxel
Wild-type Reovi...
18 Years - National Cancer Institute (NCI)
Olaparib in Subjects With Advanced Pancreatic Acinar Cell CarcinomaNCT05286827
Pancreatic Acin...
Olaparib
18 Years - National Institutes of Health Clinical Center (CC)
Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With ChemotherapyNCT01658943
Pancreatic Acin...
Pancreatic Duct...
Recurrent Pancr...
Stage IV Pancre...
Akt Inhibitor M...
Fluorouracil
Oxaliplatin
Selumetinib
18 Years - National Cancer Institute (NCI)
Carboplatin and Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Metastatic Pancreatic CancerNCT01280058
Pancreatic Acin...
Pancreatic Duct...
Recurrent Pancr...
Stage IV Pancre...
Carboplatin
Laboratory Biom...
Paclitaxel
Wild-type Reovi...
18 Years - National Cancer Institute (NCI)
Nivolumab and Ipilimumab in Treating Patients With Rare TumorsNCT02834013
Acinar Cell Car...
Adenoid Cystic ...
Adrenal Cortica...
Adrenal Gland P...
Anal Canal Neur...
Anal Canal Undi...
Angiosarcoma
Apocrine Neopla...
Appendix Mucino...
Bartholin Gland...
Basal Cell Carc...
Bladder Adenoca...
Breast Metaplas...
Cervical Adenoc...
Cholangiocarcin...
Chordoma
Colorectal Squa...
Desmoid Fibroma...
Endometrial Tra...
Endometrioid Ad...
Esophageal Neur...
Esophageal Undi...
Extrahepatic Bi...
Extramammary Pa...
Fallopian Tube ...
Fallopian Tube ...
Fibromyxoid Tum...
Gallbladder Car...
Gastric Neuroen...
Gastric Squamou...
Gastric Undiffe...
Gastrointestina...
Gestational Tro...
Giant Cell Carc...
Human Papilloma...
Intestinal Neur...
Intrahepatic Ch...
Lung Neuroendoc...
Lung Sarcomatoi...
Major Salivary ...
Malignant Odont...
Malignant Perip...
Malignant Solid...
Malignant Testi...
Metastatic Mali...
Metastatic Pitu...
Minimally Invas...
Mixed Mesoderma...
Mucinous Adenoc...
Mucinous Cystad...
Nasal Cavity Ad...
Nasal Cavity Ca...
Nasopharyngeal ...
Nasopharyngeal ...
Nasopharyngeal ...
Oral Cavity Car...
Oropharyngeal U...
Ovarian Adenoca...
Ovarian Germ Ce...
Ovarian Mucinou...
Ovarian Squamou...
Ovarian Transit...
Pancreatic Acin...
Pancreatic Neur...
Paraganglioma
Paranasal Sinus...
Paranasal Sinus...
Parathyroid Gla...
PEComa
Penile Squamous...
Peritoneal Meso...
Placental Chori...
Primary Periton...
Pseudomyxoma Pe...
Rare Disorder
Scrotal Squamou...
Seminal Vesicle...
Seminoma
Serous Cystaden...
Small Intestina...
Small Intestina...
Spindle Cell Ne...
Teratoma With S...
Testicular Non-...
Thyroid Gland C...
Tracheal Carcin...
Transitional Ce...
Ureter Adenocar...
Ureter Squamous...
Urethral Adenoc...
Urethral Squamo...
Vaginal Adenoca...
Vaginal Squamou...
Vulvar Carcinom...
Biospecimen Col...
Computed Tomogr...
Echocardiograph...
Ipilimumab
Magnetic Resona...
Nivolumab
18 Years - National Cancer Institute (NCI)
Vaccine Therapy and Sargramostim in Treating Patients With Pancreas Cancer That Cannot Be Removed By SurgeryNCT00669734
Locally Advance...
Pancreatic Acin...
Pancreatic Duct...
Stage III Pancr...
Stage IV Pancre...
Falimarev
Inalimarev
Laboratory Biom...
Sargramostim
18 Years - National Cancer Institute (NCI)
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 MutationNCT04858334
Pancreatic Acin...
Pancreatic Aden...
Pancreatic Squa...
Resectable Panc...
Resectable Panc...
Resectable Panc...
Resectable Panc...
Biospecimen Col...
Computed Tomogr...
Magnetic Resona...
Olaparib
Placebo Adminis...
18 Years - National Cancer Institute (NCI)
Carboplatin and Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Metastatic Pancreatic CancerNCT01280058
Pancreatic Acin...
Pancreatic Duct...
Recurrent Pancr...
Stage IV Pancre...
Carboplatin
Laboratory Biom...
Paclitaxel
Wild-type Reovi...
18 Years - National Cancer Institute (NCI)
The PLATINUM Trial: Optimizing Chemotherapy for the Second-Line Treatment of Metastatic BRCA1/2 or PALB2-Associated Metastatic Pancreatic CancerNCT06115499
Pancreatic Acin...
Pancreatic Aden...
Pancreatic Aden...
Pancreatic Carc...
Pancreatic Duct...
Pancreatic Squa...
Stage IV Pancre...
Nab paclitaxel
Gemcitabine
Cisplatin
Magnetic Resona...
Computed Tomogr...
Biospecimen Col...
18 Years - Alliance for Clinical Trials in Oncology
Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With ChemotherapyNCT01658943
Pancreatic Acin...
Pancreatic Duct...
Recurrent Pancr...
Stage IV Pancre...
Akt Inhibitor M...
Fluorouracil
Oxaliplatin
Selumetinib
18 Years - National Cancer Institute (NCI)
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 MutationNCT04858334
Pancreatic Acin...
Pancreatic Aden...
Pancreatic Squa...
Resectable Panc...
Resectable Panc...
Resectable Panc...
Resectable Panc...
Biospecimen Col...
Computed Tomogr...
Magnetic Resona...
Olaparib
Placebo Adminis...
18 Years - National Cancer Institute (NCI)
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: